Update on Biozorb Implant Lawsuit

Jinks Crow & Dickson, alongside Cowper Law PC and Bailey & Glasser LLP, have filed a number of lawsuits against Hologic, Inc., the manufacturer of the Biozorb® device, alleging that the manufacturer failed to warn cancer patients of the risks associated with the device. Hologic marketed Biozorb® as a tumor bed marker to assist in targeted radiation treatment after a lumpectomy.

The lawsuit involves six individual plaintiffs who all claim that Hologic Inc. failed to warn that the device may not dissolve in the body, the device may migrate, and even be expelled from the body causing severe pain and suffering.
The lawsuit also alleges that certain oncologists are being forced to use more radiation in the treatment of their patients as a result of the device which causes painful scarring of the breast and “spider veins.”
Finally, the lawsuit alleges that the device can also cause infection, skin disfigurement, breast asymmetry, the need for additional radiation, and/or an additional mastectomy surgery and Hologic failed to include any of these dangers in the Information for Use.